Search results for: 'microbiom test'

The global IoT eSIM market is at an early stage, with providers collaborating to standardize the technology. Most cellular IoT devices connect to physical SIM cards, while the rest incorporate eSIMs for testing and proof of concept (PoC). While enterprises still use physical SIM cards for IoT deployments, eSIM adoption is expected to accelerate fro...

TThis Frost & Sullivan analyst perspective presents a broad overview of Business Process Outsourcing (BPO) market demand for English proficiency for call volumes originating from the United States. It highlights the key industry trends. This market insight will provide insights into the background, trends and context for creating successful next ge...

09 Jul 2020  |  North America  |  Market Research

Post-pandemic Global Healthcare Market Outlook, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’

Infographics

×

Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...

17 Oct 2019  |  Global  |  Market Research

Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025

Growth of Biosimilars and Nutraceuticals will Drive Growth

Infographics

×

The global pharmaceuticals, biopharmaceuticals, and nutraceuticals market includes market revenues of analytical instrumentation applied in the 3 segments. Analytical instruments are applied in research, development, manufacturing, quality control, and distribution of drugs. Some key applications include (and are not limited to) drug discovery and ...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Zero-trust and Secure Remote Access , Asset Intelligence and Protection, Advanced Threat Protection, Cloud Security, Security Pentesting. Cyber Security TOE’s mission is to investigate new and emerging developments that aim to protect the network...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Innovations in AI, Cloud and Network Security, Threat and Behavioural Intelligence, Risk and Vulnerability Assessment, Access Control, Blockchain Security. Cyber Security TOE’s mission is to investigate new and emerging developments that aim to p...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Innovations in Incident Response and Detection, AI-based Cybersecurity, Zero Trust Security, Observability Platform, Vulnerability Management, Documentation Security Assessments, Quantum-safe Cryptography, Predictive Vulnerability Assessment. Cy...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Innovations in Incident Zero knowledge encryption, Endpoint security and management solutions, AI-SIEM platform, Social media security, Predictive security intelligence, Multi-Factor Authentication (MFA), AI-powered Defense. Cyber Security TOE’s ...